SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-007275
Filing Date
2021-02-08
Accepted
2021-02-08 07:00:22
Documents
12
Period of Report
2021-02-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea134808-8k_intecpharma.htm   iXBRL 8-K 25504
  Complete submission text file 0001213900-21-007275.txt   198410

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ntec-20210202.xsd EX-101.SCH 3186
3 XBRL LABEL FILE ntec-20210202_lab.xml EX-101.LAB 34582
4 XBRL PRESENTATION FILE ntec-20210202_pre.xml EX-101.PRE 22707
5 EXTRACTED XBRL INSTANCE DOCUMENT ea134808-8k_intecpharma_htm.xml XML 3604
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 21598504
SIC: 2834 Pharmaceutical Preparations